Launched and commercialized the public-health software offering.
Executive Portfolio / Software Innovation
ArmorVax
Commercializing subscription-based vaccine management software during a period of unprecedented public-health demand.
~745KReported platform users
~$1MReported first-year revenue
SaaSHosted recurring-license model
B2GPublic-sector and healthcare engagement
Career milestones
Expanded user adoption and ongoing account management.
Product commercialization
Led go-to-market strategy and executive commercialization of ArmorVax within RB Sigma, bringing a hosted subscription-based vaccine management platform to healthcare and public-sector stakeholders.
- The platform combined technology adoption, customer support, operational coordination and recurring software licensing.
Adoption and customer success
Supported adoption reaching approximately 745,000 users, according to career reporting, and approximately $1 million in first-year revenue.
- Directed commercial and government account renewals, coached account managers on retention and continuity, and connected customer feedback to technical and operating teams.
Lessons for technology leadership
Technology succeeds when teams align around a clear customer problem, establish reliable operating processes, support adoption and measure results beyond launch.
- Those lessons inform the proposed Bloyd AI Integration Framework: define outcomes before choosing technology, pilot solutions, then sustain value through measurement.
Explore further
Related portfolio sections, primary reporting and supporting context:
Selected figures reflect career-resume reporting and published company information; illustrative consulting concepts are identified as such.
← Back to selected experienceExplore five pillarsLinkedIn ↗